FLT3/IRAK4-IN-1
FLT3/IRAK4-IN-1 is a selective FLT3/IRAK4 inhibitor with the remarkable activity towards FLT3-WT (IC50 = 1.95 nM), FLT3-D835Y (IC50 = 3.22 nM) and IRAK4 (IC50 = 53.72 nM) . LT3/IRAK4-IN-1 has relatively low toxicity to normal bone marrow cells, can effectively promote cell apoptosis, and has the potential to overcome drug resistance. FLT3/IRAK4-IN-1 can be used for research on acute myeloid leukemia (AML) [1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; FLT3; IRAK
Related Pathways
Apoptosis; Immunology/Inflammation; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
FC1=CC=CC(N2C=CC3=C2N=C(N=C3)NC4=CC(N[C@H]5CCNC5)=CC=C4)=C1
Molecular Formula
C22H21FN6
Molecular Weight
388.44
References & Citations
[1]Yuan H et al. Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors. Eur J Med Chem. 2025 Jun 13;296:117845. doi: 10.1016/j.ejmech.2025.117845. Epub ahead of print. PMID: 40532500. https://pubmed.ncbi.nlm.nih.gov/40532500/|[2]Yuan H et al. Discovery of pyrrolo[2,3-d]pyrimidine derivatives as novel FLT3/IRAK4 inhibitors. Eur J Med Chem. 2025 Jun 13;296:117845. doi: 10.1016/j.ejmech.2025.117845. Epub ahead of print. PMID: 40532500.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880158-500 1x 500 µL
Cytokeratin 17 (E3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401081-100 1x 100 µL
CD45RO (190-2F2.5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
